ANSA BIOTECHNOLOGIES
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.
ANSA BIOTECHNOLOGIES
Industry:
Biotechnology Life Science Therapeutics
Founded:
2018-05-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.ansabio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
83.42 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default LetsEncrypt Content Delivery Network Google Apps For Business Microsoft Azure DNS Typekit DMARC Lorem Ipsum
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Feldan Therapeutics
Feldan Therapeutics has developed a patented peptide-based technology platform.
Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Humboldt Fund
Humboldt Fund investment in Series A - Ansa Biotechnologies
RA Capital Management
RA Capital Management investment in Series A - Ansa Biotechnologies
Fifty Years
Fifty Years investment in Series A - Ansa Biotechnologies
PEAK6 Investments LLC
PEAK6 Investments LLC investment in Series A - Ansa Biotechnologies
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series A - Ansa Biotechnologies
Fiscus Ventures
Fiscus Ventures investment in Series A - Ansa Biotechnologies
Northpond Ventures
Northpond Ventures investment in Series A - Ansa Biotechnologies
Horizons Ventures
Horizons Ventures investment in Series A - Ansa Biotechnologies
Ischyros New York
Ischyros New York investment in Series A - Ansa Biotechnologies
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series A - Ansa Biotechnologies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-23 | Ansa Biotechnologies Expands Leadership Team with Appointment of Jeremiah Hanes, Ph.D. as Senior Vice President of R&D |
Official Site Inspections
http://www.ansabio.com
- Host name: 115.68.215.35.bc.googleusercontent.com
- IP address: 35.215.68.115
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
